Sort
82,697 grants matching “vaccine development”
Development of nonhuman primate reference transcriptome resources
$759,371Michael G Katze · University Of Washington · R24 · FY2014 · OD
Vanderbilt Meharry Developmental CFAR
$759,365Vanderbilt University · P30 · FY2004 · AI
Innate Immunity
$759,351Bali Pulendran · Emory University · U19 · FY2011 · AI
PfSEA-1 based vaccines for falciparum malaria
$759,349Jonathan D. Kurtis · Brown University · R01 · FY2018 · AI
Novel nanobodies to prevent and treat SARS-CoV-2 and other pathogenic human coronaviruses
$759,331Lanying Du · Georgia State University · R01 · FY2023 · AI
Novel nanobodies to prevent and treat SARS-CoV-2 and other pathogenic human coronaviruses
$759,331Lanying Du · Georgia State University · R01 · FY2025 · AI
A cross protective multivalent vaccine for Shigella and ETEC
$759,261David A Sack · Johns Hopkins University · R01 · FY2024 · AI
REstoring mental health after COVID-19 through commUnity-based Psychological services in New York City (RECOUP-NY)
$759,241Brandon Alan Kohrt · George Washington University · R01 · FY2022 · MH
Dynamics of the protective vaccine-induced human influenza neuraminidase B cell response
$759,187James J Kobie · University Of Alabama At Birmingham · R01 · FY2022 · AI
Development and In Vivo Characterization of Safety-Enhanced RhCMV/SIV Vectors
$759,095Louis J. Picker · Oregon Health & Science University · R01 · FY2013 · AI
The role of Trained Immunity and Mitochondrial dysfunction on INnate immunity in children and adolescents aGing with PHIV (TIMING-PHIV)
$759,093Nicholas T. Funderburg · Ohio State University · U01 · FY2022 · AI
B-cell repertoire analysis in influenza vaccination and infection
$759,032Hua-Xin Liao · Boston Children'S Hospital · P01 · FY2012 · AI
Drug Repurposing Screening for Zika Virus Infection
$759,021Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR
Immunologic Basis for Broad Protection against Enteric Fever Salmonella
$759,011Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2015 · AI
Understanding the mechanisms of antibody-mediated transcytosis of ZIKV within the placenta
$759,003Mehul Shamal Suthar · Emory University · R01 · FY2020 · AI
Defining Sex-Specific Systemic and Gut Inflammatory Profiles in People Living with HIV
$758,985Stacey Abigail Smith · Emory University · R01 · FY2025 · AI
Elucidating the functions of red blood cell factors in malaria parasite invasion
$758,965Elizabeth S. Egan · Stanford University · R01 · FY2023 · HL
Expanding the use of Tetrahymena as a protein expression platform
$758,950Paul Colussi · Tetragenetics, Inc. · R44 · FY2016 · GM
Novel recombinant Rotavirus vaccine utilizing the probiotic microorganism Lactobacillus acidophilus
$758,912Gregg A Dean · Colorado State University · R01 · FY2023 · AI
Glycosylation Mutants of Leishmania
$758,867Stephen M Beverley · Washington University · R01 · FY2010 · AI
Epitope-Based Design and Modified RNA Platform for Bivalent Marburgvirus Vaccine
$758,862Alexander Bukreyev · University Of Texas Med Br Galveston · R01 · FY2021 · AI
Viral Diversity and Pathogenicity in Mucosal Respiratory and Gastrointestinal Disease
$758,850Mary Kolb Estes · Baylor College Of Medicine · U19 · FY2020 · AI
Eliminating the latent reservoir by targeted in vivo delivery of HIV-specific CARs
$758,836James L Riley · University Of Pennsylvania · R01 · FY2025 · AI
Cellular and molecular programming of lung resident T cell memory
$758,832Jacob E Kohlmeier · Emory University · R35 · FY2024 · HL
A Novel HIV-1 Vaccine Targeting the 12 protease Cleavage Sites
$758,828Ma Luo · University Of Manitoba · R01 · FY2016 · AI